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Tcf7l2 plays pleiotropic roles in the 
control of glucose homeostasis, 
pancreas morphology, 
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Type 2 diabetes (T2D) is a disease characterized by impaired insulin secretion. The Wnt signaling 
transcription factor Tcf7l2 is to date the T2D-associated gene with the largest effect on disease 
susceptibility. However, the mechanisms by which TCF7L2 variants affect insulin release from β-cells 
are not yet fully understood. By taking advantage of a tcf7l2 zebrafish mutant line, we first show that 
these animals are characterized by hyperglycemia and impaired islet development. Moreover, we 
demonstrate that the zebrafish tcf7l2 gene is highly expressed in the exocrine pancreas, suggesting 
potential bystander effects on β-cell growth, differentiation and regeneration. Finally, we describe 
a peculiar vascular phenotype in tcf7l2 mutant larvae, characterized by significant reduction in the 
average number and diameter of pancreatic islet capillaries. Overall, the zebrafish Tcf7l2 mutant, 
characterized by hyperglycemia, pancreatic and vascular defects, and reduced regeneration proves to 
be a suitable model to study the mechanism of action and the pleiotropic effects of Tcf7l2, the most 
relevant T2D GWAS hit in human populations.
The world prevalence of diabetes is estimated to be 9% among the adult population (aged 20–79 years). Diabetes 
mellitus is a disease of metabolic dysregulation; initially diagnosed as hyperglycaemia, ultimately results in blood 
vessel defects that lead to various complications such as cardiovascular disease and stroke, retinopathy, nephrop-
athy, neuropathy, and impaired wound healing. Relative or absolute deficiency of insulin-producing β cells in 
pancreatic endocrine islets underlies the pathogenesis of both type 1 and type 2 diabetes mellitus (T1D and T2D, 
respectively). Thus, there is considerable interest in understanding the signalling mechanisms that stimulate pan-
creatic islet cell growth and differentiation.
A genome-wide association study (GWAS) performed in 2006 first identified a link between TCF7L2 poly-
morphisms and the risk of T2D among European and American populations1. Among common genetic lesions 
linked to T2D, polymorphisms in the TCF7L2 gene provide the strongest association with the disease manifes-
tation. This gene encodes for a transcription factor, which, like other members of the TCF/LEF family, interacts 
with β-catenin as a downstream effector of the Wnt signalling pathway. Wnt proteins are a family of highly con-
served secreted proteins that regulate multiple developmental processes, including proliferation of organ-specific 
stem/progenitor cell populations, tissue growth and patterning, and cell fate determination in diverse ontogenetic 
processes. Interestingly, many studies point to a fundamental role for the Wnt pathway in β-cell biology, but more 
research is needed to determine whether this molecular signalling is active in β cells in vivo2.
As far as concerns the specific expression and functional role of the Wnt signalling effector Tcf7l2 in β cells, 
current studies are not yet fully conclusive. In the work of Columbus et al.3 qRT-PCR analysis has been carried out 
to analyse Tcf7l2 expression in rodent gut, pancreas, isolated pancreatic islets, and cultured cell lines. The expres-
sion of Tcf7l2 was relatively lower in the pancreas compared to the gut, and the immuno-staining failed to detect 
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Tcf7l2 signals in mouse islets3. Functional studies on Tcf7l2 in murine models and humans have indicated that 
individuals with TCF7L2 polymorphisms exhibit impaired insulin secretion and enhanced rate of hepatic glu-
cose production4–7. However, whether Tcf7l2 directly regulates the function of β-cells remains controversial8–10. 
For instance, Boj et al. conclude that Tcf7l2 is not important for β-cell function in mice but it rather controls the 
hepatic response to perinatal and adult metabolic demand11. On the other hand, other studies report altered β-cell 
formation and function upon genetic depletion of Tcf7l2 during pancreas development12–16.
Given the existing controversy in the literature over the relative importance of Tcf7l2 for proper development 
of β cells, liver and/or other tissues, as well as the contributions of extra-pancreatic tissues to risk variants activity 
on diabetes susceptibility17, the present study has been designed to investigate the general effects of Tcf7l2 in a 
simple model: the zebrafish (Danio rerio). This vertebrate organism offers numerous advantages that have been 
exploited in this study. In particular, the accessibility and optical clarity of the zebrafish embryos allow cell manip-
ulation and sophisticated in vivo imaging approaches that would be far more difficult in a mammalian model. 
Importantly, the zebrafish pancreas shares important similarities with its human counterpart. In both species the 
pancreas consists of an exocrine compartment (formed by acinar cells), producing digestive enzymes secreted 
into a ductal system and transported to the digestive tract, and an endocrine compartment, represented by islets 
embedded in a dense capillary network, playing a critical role in blood sugar homeostasis18.
By taking advantage of an available zebrafish tcf7l2 mutant (previously named tcf4), bearing a functionally null 
allele19, we present here a detailed analysis on the role of Tcf7l2 in glucose homeostasis and in the development, 
regeneration and vascularization of the pancreatic islet.
Results
Postprandial increase of blood glucose in heterozygous tcf7l2exI/+ adults. In order to prove the 
suitability of zebrafish as a model for Tcf7l2-dependant Type 2 Diabetes (T2D), we analysed the blood glucose 
levels in a mutant background. Specifically, we focussed on the zebrafish tcf7l2exI mutation, which was isolated 
from a zebrafish library mutagenized with N-ethyl-N-nitrosourea (ENU)19. The tcf7l2exI allele carries a G-to-A 
substitution within the splice donor site of intron 1; this mutation leads to intron retention and formation of a 
short-truncated protein. Notably, tcf7l2exI/exI homozygous mutants are known to have an intestinal phenotype due 
to proliferation defects19. Only less than 1% of homozygous tcf7l2exI/exI fish can reach the adult stage, as most of 
them die by 6 weeks post fertilization. Therefore, in this study, all experiments performed to evaluate the role of 
tcf7l2 during adulthood have been carried out on tcf7l2exI/+ heterozygous mutants.
In order to characterize the metabolic phenotype of tcf7l2 heterozygotes, we performed three sets of experi-
ments in which we measured changes of blood glucose concentration during different dietary conditions by using 
the protocol of Eames and colleagues20.
In the first dietary condition, we measured changes in glucose level in the absence of food by fasting tcf7l2exI/+ 
heterozygous fish for 4 days. After 4-day fasting we could not detect differences in the glycaemia between wild 
type and tcf7l2exI/+ individuals. In the second dietary condition we induced hyperglycaemia by placing zebrafish 
in a 1% glucose solution; as already reported by Gleeson and colleagues21, the immersion in a glucose solution 
resulted in increased blood glucose without any statistically significant difference between wild type and tcf7l2exI/+ 
fish (Fig. 1A). However, despite constant immersion in 1% glucose, the glycaemic peak is transient and blood 
glucose levels stabilize to values higher than normal21. For this reason, we chose to analyse the blood glucose level 
after 4 days of continued immersion in 1% glucose. Nonetheless, also in this condition, blood glucose level was 
similar between tcf7l2+/+ controls and tcf7l2exI/+ heterozygotes. Finally, in the third dietary condition we deter-
mined changes in glucose levels 30 minutes postprandial. In this latter test, we could reveal a significant increase 
of blood glucose level in tcf7l2exI/+ heterozygous animals compared with tcf7l2+/+ controls (Fig. 1A) indicating 
that in zebrafish, under specific nutritional contexts, partial loss of tcf7l2 activity can lead to an increase of blood 
glucose, a condition that somehow mimics T2D.
Next, we applied a novel, non-lethal and reliable method for repeated blood collection from adult zebrafish22, 
and combined it with a β-cell ablation strategy in order to evaluate, from glucose metabolism data, the regenera-
tive capacity of the β-cell mass in heterozygous tcf7l2exI/+ mutants and wt controls.
Wt and tcf7l2exI/+ adults in Tg(ins:NTR-mCherry) background were treated with 10 mM Metronidazole (Mtz) 
for 24 hours23 leading to a severe hyperglycaemia. To investigate the regenerative capacity of the pancreatic islet 
after NTR/Mtz-mediated ablation, we measured the blood glucose in wt and tcf7l2exI/+ fish at different time points 
(Fig. 1B). In control adults, we observed a significant decrease in blood glucose only 7 days after treatment, 
indicating a recovery of β cells function, and normalization of glucose levels at 28 days. In contrast, Mtz-treated 
tcf7l2exI/+ animals showed high glucose levels three weeks after Mtz treatment and displayed full recovery at 35 
days (Fig. 1B).
Canonical Wnt signalling and tcf7l2 expression in the pancreas. Given this identified association 
between Tcf7l2 haplo-insufficiency and hyperglycaemia, we set out to investigate the potential role of canonical 
Wnt signalling, of which Tcf7l2 is a downstream effector, in endocrine pancreas development and/or function. 
The main endocrine islet of the zebrafish pancreas is embedded in the head of exocrine tissue24, 25. To detect 
canonical Wnt signalling activation in the endocrine pancreas, we crossed the Tg(7xTCFXla.Siam:nlsmCherry)ia5 
strain, a reporter line for in vivo TCF/β-catenin activity26, with Tg(ptf1a:EGFP), a transgenic line that specifically 
labels the exocrine tissues of the developing pancreas. In this way, we could detect in vivo a weak expression of 
canonical Wnt signalling in the endocrine islet from 9 dpf (Supplementary Figure 1). Then, we analysed tcf7l2 
and insulin expressions by double fluorescent whole mount in situ hybridization. In our conditions, we could not 
detect the expression of tcf7l2 in β cells at any of the considered developmental stages (72 hpf, 4 dpf and 7 dpf), 
while its expression was significant in the exocrine pancreas and intestine (Fig. 2A,B). This is in agreement with 
published data on the function of tcf7l2 in zebrafish19. However, to rule out the possibility of low tcf7l2 expression 
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levels, below the whole-mount in situ hybridization detection threshold, we analysed its expression in different 
pancreatic cell types by RNAseq. The expression level of tcf7l2 and other members of the TCF/LEF gene family 
(tcf7l1a, tcf7l1b, tcf7 and lef1) was obtained from RNAseq datasets prepared from purified pancreatic endocrine 
cells (β-, α- and δ-cells) as well as from the exocrine acinar cells isolated from adult zebrafish27.
As shown in Fig. 2C, tcf7l2 is expressed in acinar and at lower levels in δ-cells while no expression was detected 
in β and α cells. Additionally, tcf7l1a is mainly expressed in the three endocrine cell types while tcf7l1b is mainly 
detected in δ cells. Finally, lef1 and tcf7 were not detected in any of the considered pancreatic cell types. These 
results confirmed that tcf7l2 is not expressed in β cells but only in δ and acinar cells.
As far as concerns the possible expression of tcf7l2 in vascular cells, we could not detect significant signals 
in these cell types by whole-mount in situ hybridization, although RT-PCR could detect a good correlation 
(R2 = 79%) between the amplification of tcf7l2 transcripts and the amount of endothelial-specific GFP in a set of 
considered samples (transgene: Tg(fli1a:EGFP)y1) (Fig. 2D). This observation has been further validated by quan-
titative PCR performed on GFP+ and GFP− cells sorted from dissociated 6-dpf embryos of the Tg(fli1a:EGFP)y1 
Figure 1. Postprandial increase of blood glucose in heterozygous tcf7l2exI/+ adults. Blood glucose levels in 
wild type and tcf7l2exI/+ adult fish (7 mpf) under different dietary conditions (Fasted, 1% Glucose and 1 h 
Postprandial). Data were obtained from five fishes per genotype, repeated in 2 different experiments. Average 
values are given for each sample and standard errors of the mean are indicated; *p < 0.05. (B) Blood glucose 
levels after 75 minute postprandial in wild type and tcf7l2exI/+ adult fish (4 mpf), monitored during recovery 
after MTZ treatment. Values represent the mean ± SEM. Red asterisks indicate that blood glucose levels of 
tcf7l2exI/+ mutants in ins:NTR-mCherry transgenic background are significantly different from tcf7l2+/+ controls; 
**p < 0.01 and *p < 0.05; n = 5 individuals per genotype. Blue “ns” (not significant) indicates no statistical 
difference between tcf7l2+/+ in ins:NTR-mCherry transgenic background and tcf7l2+/+ controls at 7, 14, 21, 28 
and 35 days after treatment with MTZ.
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Figure 2. Canonical Wnt signalling and tcf7l2 expression in the pancreas. (A,B) Single and double fluorescent 
WISH comparing the expression of tcf7l2 and insulin at 7 dpf. Images show confocal single planes at 7 dpf 
at different magnification of (A) (20x) and (B,B’,B”) (60x). Merging the green and red channels identifies 
regions with distinct gene expression of the two genes (B’,B”). in: intestine, e: exocrine tissues, i: principal 
islet. Scale bar = 100 μm. (C) Expression level (count normalized by library size) obtained by RNAseq of 
different Tcf/Lef genes in α, β, δ and acinar cells from adult zebrafish. (D) tcf7l2 and egfp expression values 
from 10 different tissues derived from transgenic Tg(fli1a:EGFP)y1 adult fish. Brain (Br), Eye (Ey), Gills (Gi), 
Gut (Gu), Heart (He), Kidney (Ki), Muscle (Mu), Pancreas (Pa), Vessels (Ve). (E) Enrichment of GFP+ cells 
from Tg(fli1a:EGFP)y1 zebrafish embryos. Relative expression of indicated genes, in GFP+ (green bars) and 
GFP− (grey bars) cells, determined by quantitative RT-PCR. Relative expression levels were determined by 
normalization to arp. Values represent the mean ± SEM. Asterisk above column indicate statistical differences 
among groups.
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strain, a transgenic line fluorescently labelling endothelial cells (and, to a lesser extent, hematopoietic and phar-
yngeal arc cells)28. This analysis demonstrated that GFP+ cells are also positive to tcf7l2 (Fig. 2E). All together, 
these results support the hypothesis that tcf7l2 might be expressed in endothelial cells, thus exerting a potential 
role also in blood vessels.
tcf7l2 is required to regulate insulin expression and exocrine pancreas formation in tcf7l2exI/exI 
homozygous mutants. To test the requirement of tcf7l2 for indirect regulation of insulin expression in β 
cells, we compared the insulin expression in tcf7l2exI/exI homozygous mutants and tcf7l2+/+ controls. When endog-
enous expression of insulin mRNA was analysed by whole-mount in situ hybridization at 9 dpf, we observed a sig-
nificant diminution of insulin expression levels in tcf7l2exI/exI mutants, compared to wt siblings (Fig. 3A,A’). Hence, 
to gain further insights into the functional role played by tcf7l2, we examined in vivo the effects of its inactivation 
on the expression of endocrine and exocrine markers. The first step was the phenotypic characterization of tcf7l2 
mutants by using a transgenic zebrafish line that carries the ins:DsRed transgene, thus allowing to monitor in vivo 
both insulin reporter expression and β-cell number in tcf7l2 mutants and their controls (Fig. 3B,B’). A quantita-
tive analysis of insulin transgene expression, shown in Fig. 3C at 16 dpf, revealed a decreased signal in mutants 
compared to controls (Fig. 3C), confirming our observations on endogenous insulin expression. Although the 
amount of β cells in tcf7l2exI/exI mutants was not affected at early stages of development (shown at 7 dpf in Fig. 3D), 
a significant decrease of ins:DsRed positive cells was observed at 16 dpf in tcf7l2exI/exI homozygotes, compared with 
control sibs (16 dpf, Fig. 3D).
The alterations of the exocrine pancreatic morphology is frequently observed in T1D and T2D, and is referred 
as exocrine pancreatic insufficiency (EPI)29. However, the role of Tcf7l2 in the exocrine pancreas formation or 
maintenance is not known. Hence, we performed the phenotypic characterization of tcf7l2 mutants using a 
transgenic zebrafish line harbouring the ptf1a:DsRed transgene, an in vivo marker of pancreatic exocrine cells. 
As shown in Fig. 3E–E’, in tcf7l2exI/exI mutants both ptf1a:DsRed expression and exocrine pancreas morphology 
were altered, suggesting that in zebrafish, from the 16 dpf stage, tcf7l2-mediated activities significantly affect 
exocrine pancreas development. A quantitative analysis of Tg(ela3l:E2Crimson), an alternative exocrine marker, 
shown in Fig. 3F at 14 dpf, revealed a decreased signal in tcf7l2exI/exI mutants, confirming our observations on 
Tg(ptf1a:DsRed) at 16 dpf. The ela3l marker was not affected in mutants at 7 dpf (Fig. 3F).
The adult pancreas of tcf7l2exI/+ heterozygous mutants is morphologically altered. As shown 
before, our analysis of pancreatic phenotypic defects at 16 dpf has been performed in tcf7l2exI/exI homozygous 
mutants. To study this phenotype in adults, we used tcf7l2exI/+ heterozygous mutants, given that tcf7l2exI/exI 
homozygous fish are not viable from 6 wpf.
The crossing of tcf7l2exI/+ heterozygotes with Tg(ins:dsRED) allowed us to study in vivo the effect of tcf7l2 
mutations on the adult pancreas morphology. Figure 4A and B show the endocrine pancreas in wild type and 
tcf7l2exI/+ adults. Although the body size of tcf7l2exI/+ heterozygous mutant was slightly smaller when compared 
with wt, morphometric analysis of the pancreas of tcf7l2exI/+ zebrafish showed allometric reduction of overall 
organ size including the exocrine (not shown) and the endocrine compartment (Fig. 4A,B). Specifically, we could 
observe a reduction in the area of endocrine pancreas, with a decrease in the number of β cells (Fig. 4B’). A sim-
ilar phenotype was present also in the secondary islets (4B”). To assess the phenotype of endocrine and exocrine 
pancreas in more detail, we performed histological analysis of pancreatic paraffin sections from 9-month-old 
adults, detecting more adipose tissue in mutant exocrine pancreas compared to wt (Supplementary Figure 2). 
This analysis confirmed that the pancreatic structure of tcf7l2exI/+ mutants was more compact. No significant dif-
ferences in the number of α cells were found between the tcf7l2exI/+ and tcf7l2+/+ (Supplementary Figure 3). These 
data indicate that tcf7l2 might play a role in the control of β-cell structure and number, serving as an important 
regulator of gene expression and islet cell coordination.
Given the developmental alterations displayed by the adult endocrine pancreas, we examined the role of tcf7l2 
in the exocrine compartment for possible defects. To address this question, we crossed the Tg(ptf1a:DsRed) and 
Tg(ela3l:E2Crimson) lines with tcf7l2exI/+ mutants. As illustrated in Fig. 5A and B, in the tcf7l2exI/+ adult mutants 
the acinar organization was difficult to discern. The elastase regulatory sequence drives highly specific expression 
of Crimson in the exocrine pancreas of both larvae and adults, allowing the observation of exocrine cell differen-
tiation, proliferation, and morphogenesis in vivo. By confocal analysis of the wild types in Tg(ela3l:E2Crimson) 
background (Fig. 5C), the acinar cells and their lobular organization were clearly discerned, while in tcf7l2 
mutants (Fig. 5D) these histological features of exocrine tissue and acinar organization were not comparably 
organized, displaying acinar cells more dispersed and surrounded by abundant adipose tissue. We confirmed 
this arrangement of the exocrine tissue by histological analyses (Fig. 5E and F). The alteration of the morphology 
and organization of the exocrine tissue in mutants indicates a potential tcf7l2-specific function in exocrine tissue 
maturation.
The role of vascular endothelium in pancreas development and β-cell regeneration. Wnt 
signalling and Tcf7l2 are fundamental in vascular development and, specifically, in endothelium formation30. 
Moreover, studies carried out in mouse and Xenopus have shown that, in the absence of vascular endothelial 
cells, Pdx1-positive endoderm cells fails to differentiate into β cells31. Endothelial cells are known to be exten-
sively present in the pancreatic islet of zebrafish by approximately 52 hpf24, and we were able to clearly detect the 
first endothelial cells in the endocrine pancreatic primordium already at 30 hpf (Supplementary Figure 4A,B,C). 
Thus, we reasoned that the role of Tcf7l2 in pancreas development could be mediated through the control of 
pancreatic vasculogenesis and the maintenance of pancreatic endothelium. To assess in vivo the possible role of 
Tcf7l2 in endothelial cells development and zebrafish pancreas formation, we analysed the vascular system in 
tcf7l2 mutants by using a transgenic line expressing GFP under the control of the zebrafish fli1a promoter28. The 
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Figure 3. tcf7l2 is required for regulation of insulin expression and exocrine pancreas development. Analysis 
of insulin in control embryos (A) and in tcf7l2exI/exI mutants (A’) by in situ hybridization. Lateral views of the 
pancreatic area are shown with the anterior side to the right. The expression of insulin is significantly reduced 
in the mutants. (B–B”) Analysis of pancreatic islet in tcf7l2exI/exI mutant in Tg(ins:dsRed) background. 2D 
projections of confocal Z-series images of DsRed expression in living Tg(ins:DsRed) embryos at 16 dpf. (B) wt; 
(B’) homozygous mutant. (C) Graphic presentation of the integrated density of fluorescence in the red channel 
in tcf7l2exI/exI mutant and wild-type sib controls in Tg(ins:dsRed) at 16 dpf. (D) Quantification of the number of β 
cells during juvenile growth of tcf7l2exI/exI and control siblings. (E–E’) Analysis of exocrine pancreas in tcf7l2exI/exI 
mutant in Tg(ptf1a:dsRed), (E) wt and (E’) mutant at 16 dpf. (F) Graphic presentation of the integrated density 
of fluorescence in the red channel in tcf7l2exI/exI mutant and wild-type sib controls in Tg(ela3l:Crimson) at 7 and 
14 dpf. Data were obtained from 6 individuals per genotype, repeated in 2 different experiments. All reference 
to phenotypes was confirmed by genotyping. The integrated density was obtained using the Fiji software. Values 
represent the mean ± SEM. Asterisk above column indicate statistical differences among groups *p < 0.05.
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Fli1 transcription factor is a highly-conserved member of the ETS-domain family of transcriptional activators 
and repressors. Transgenic Tg(fli1:eGFP)y1 zebrafish label the endothelial lineage, from angioblasts, during early 
development32 and during normal or defective pancreas development24. Hence, tcf7l2exI/+ mutants were crossed 
with Tg(fli1:eGFP)y1. The analysis shows a decrease in the number and volume of pancreatic islet capillaries in 
tcf7l2exI/exI mutants (Fig. 6C). In particular, tcf7l2 and wt zebrafish blood vessels of the islet region differ both in 
density and in the diameter of the capillaries, indicating that the pancreatic vascularization is clearly impaired in 
tcf7l2 mutants (Fig. 6D).
To verify if this altered vascularization can underlie observed β-cell defects in tcf7l2 mutants, we performed a 
drug-mediated perturbation of blood vessels and analysed its effects on the β-cell compartment. Specifically, we 
treated 2 dpf double transgenic embryos Tg(kdrl:mCherry-ins:EGFP) with the anti-angiogenic drug Pazopanib 
(as described in Li et al.33) (Supplementary Figure 4D,E). After three days of drug treatment, we clearly detected 
a reduction of kdrl:mCherry-positive small calibre vessels in the area surrounding the endocrine islet, in parallel 
Figure 4. Morphology of β cells in wt and tcf7l2exI/+ heterozygous adults. (A,B) Whole gut tissue extracted 
from 9 month-old wt and tcf7l2exI/+ fish in Tg(ins:dsRed) background. Dashed circle: primary islet. Arrowheads: 
secondary islets and individual β cells extending caudally along the intestine. Examples of projection of a 
confocal stack image (A’,B’) of primary islets and secondary islet (A”,B”). (C) Quantification of β cells in 9 
months old fish. Data were obtained from 3 individuals per genotype, repeated in 2 different experiments.
www.nature.com/scientificreports/
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with a significant decrease of ins:EGFP transgene expression, suggesting that a correct vascularization of the pan-
creatic islet is required for normal insulin expression in β cells.
Wnt signalling is extensively involved in tissue proliferation in multiple developmental contexts17; thus, in 
order to understand the possible contribution of tcf7l2 to proliferation, mitosis was measured in mutant by 
DNA-incorporation assays using the thymidine analogue EdU. For the EdU incorporation assays, control animals 
and tcf7l2 mutants were incubated with EdU at 6 dpf and analysed at 9 dpf. The overall image of the pancreatic 
region shows that the mutants have less EdU+ cells than controls, indicating that the proliferation rate is strongly 
reduced in mutants at 9 dpf (Supplementary Figure 5). Notably, a similar phenotype, with a loss of proliferation 
at the base of the intestinal folds of the middle and distal parts of the intestine, was observed by Muncan et al.19.
On the other way, to verify if, in parallel to the decreased proliferation, increased cell death could contribute 
to the pancreatic tcf7l2 phenotype, acridine orange (AO) staining was performed at 11 dpf, detecting a larger 
amount of AO-positive dying cells in mutants compared to controls (Supplementary Figure 5).
Figure 5. Morphology of exocrine pancreas in wt and tcf7l2exI/+ heterozygous adults. (A,B) Projection of a 
confocal stack image of exocrine pancreas extracted from 9-month-old wt and tcf7l2exI/+ fish in Tg(ptf1a:DsRed) 
background. (C,D) Projection of a confocal stack image of exocrine pancreas extracted from 6-month-old wt 
and tcf7l2exI/+ fish in Tg(ela3l:Crimson) background. Dashed circles indicate typical acinar structures. Scale 
bar = 50 μm. (E,F) H&E staining of acinar cells (ac) of wt (E) and tcf7l2exI/+ (F) at 9 mpf.
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As these are global analyses, performed on the whole organ, decreased proliferation or survival at the vascu-
lar level are not excluded. Thus, our findings indicate that the Wnt effector Tcf7l2 has a conserved function in 
formation, maintenance and proliferation of cells in the pancreatic region, suggesting that abnormalities in the 
Figure 6. Defects in vascular endothelium and pancreas development of tcf7l2exI/exI homozygous larvae. (A,B) 
Analysis of pancreatic islet and blood vessels inside and around the pancreas of tcf7l2 mutants and wild-type 
sib controls in Tg(fli1a:EGFP/ins:DsRed) background. Representative images were taken at 18 dpf by confocal 
microscopy at 20x magnification. (C) Graphic presentation of the integrated density of fluorescence in the 
red and green channel in tcf7l2exI/exI mutant and wild-type sib controls at 18 dpf. The regions for the analysis 
of integrated density of fluorescence are indicated by white boxes. Data were obtained using Fiji software. 
(D) Analysis and graphic presentation of vessels diameter; the mutant is characterized by decreased vessel 
diameter. Data were obtained from five individuals per genotype. All reference to phenotypes was confirmed by 
genotyping; *p < 0.05.
www.nature.com/scientificreports/
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generation of vessels may be a consequence of impaired proliferation/survival of endothelial cells, and that altered 
interaction between endothelial and endocrine cells could lead to anomalies in pancreas formation and function.
Since β-cell regeneration relies on nutritional factors delivered by the vasculature as well as on non-nutritional 
metabolic cues that rely on the systemic circulation, we sought to evaluate the β-cell mass during regeneration in 
tcf7l2 mutants.
Wt and tcf7l2exI/exI embryos in Tg(ins:NTR-mCherry) background were treated with 7 mM Metronidazole 
(Mtz) starting from 4 dpf23. By 5 dpf (24 hr of treatment), the incubation of transgenic larvae with the pro-drug 
Mtz resulted in reduced β-cell mass. To investigate the regenerative capacity of the pancreatic islet after NTR/
Mtz-mediated ablation, wt and tcf7l2exI/exI larvae were washed several times in fresh Mtz/DMSO-free medium and 
allowed to recover for 48 hr. Confocal imaging revealed that there is a quick and complete regeneration of β cells 
in the wt but not in tcf7l2exI/exI mutants (Supplementary Figure 6).
Heterozygous tcf7l2exI/+ adults have a reduced rate of caudal fin regeneration at 7 mpf. In 
order to study the regenerative performances of tcf7l2 mutants in other anatomical districts, the caudal fin of 
control and tcf7l2exI/+ heterozygous individuals were amputated as previously described34. Images were collected 
at 72 hours post-amputation. The newly regenerated tissue was traced using Image J software, yielding the area of 
regeneration. In order to normalize for the differences in initial fin size, we divided this area by the dorso-ventral 
length of the fin at the amputation site. Tcf7l2 heterozygous zebrafish exhibited a statistically significant reduction 
compared to controls (Fig. 7B). Tissue regeneration requires the coordination of cell proliferation and apoptosis 
and we hypothesized that the reduction documented above could be due to alterations in either of these two 
processes. The results show that in tcf7l2exI/+ mutants there is a decrease of the proliferative potential of the regen-
erating fin. A decrease in cell proliferation was also observed in tcf7l2exI/exI at 9 dpf by labelling S-phase nuclei with 
the click-iT EdU cell proliferation assay (Supplementary Figure 5C,D).
Discussion
After the demonstration of a very strong association between the risk of T2D and specific polymorphisms in 
the TCF7L2 gene1, this effector of Wnt signalling has started to draw global attention4, 35. Therefore, in this study 
Figure 7. Heterozygous tcf7l2exI/+ adults have a reduced rate of caudal fin regeneration. (A) Bright field live 
images of unamputated and regenerating fins in wild type and tcf7l2exI/+ after 72 hours post-amputation. The 
area of regeneration was determined and the original cut line was used to normalize fin size differences. (B) 
Graphic presentation of the regeneration rate in controls and tcf7l2exI/+ mutant fish. Data were obtained from six 
fishes per genotype, repeated in 3 different experiments.
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our first goal has been to verify if mutations in the orthologous zebrafish gene could elicit a diabetic phenotype. 
To this purpose, we tested tcf7l2 mutants for their blood glucose levels, detecting elevated post-prandial glucose 
levels and thus assessing that this mutant line can be a good model for Tcf7l2-dependent T2D.
In the literature, data show that individuals carrying T2D risk alleles at the TCF7L2 locus, and those with 
T2D itself, have increased TCF7L2 transcript levels5. However, in human islets both TCF7L2 suppression12 and 
over-expression5 have been reported to cause impaired glucose-stimulated insulin secretion. These divergent 
effects raise concerns about the biological relevance of perturbing total TCF7L2 transcript levels. T2D risk var-
iants have been proposed to influence TCF7L2 splicing patterns, raising the possibility that the ratio of func-
tionally distinct mRNA isoforms, rather than the overall level of expression, could determine the pancreatic 
phenotype36.
These studies have directed our attention to the analysis of Tcf7l2 expression and Wnt signalling activity in 
zebrafish pancreatic islets, especially in the pancreatic β cells. Literature data present contrasting findings about 
Tcf7l2 expression in the mouse pancreas; notably, previous analyses have failed to detect Tcf7l2 by immunohisto-
chemistry in mouse pancreatic islets37. In our study, the expression levels of tcf7l2 and other members of the TCF/
LEF gene family (tcf7l1a, tcf7l1b, tcf7 and lef1), revealed by RNAseq in the zebrafish adult pancreatic cell types, 
indicate that tcf7l2 is not expressed in β cells while it is present in δ cells and, at higher levels, in the acinar tissue. 
This finding has been further supported by observations with whole mount in situ hybridization that confirmed 
the expression of tcf7l2 in the exocrine pancreas, intestine and liver. Overall, our analysis of tcf7l2 expression in 
the zebrafish model confirms a pattern like the mouse system, but refines its distribution in the pancreatic islet, 
detecting signals in somatostatin-producing δ cells. As in mouse, our study also failed to detect signals in β cells, 
suggesting a non-cell autonomous effect of Tcf7l2 on β-cell function.
In T2D, β-cell insulin response to glucose is blunted. These changes are associated with structural and func-
tional changes in pancreatic islets. Hence, β-cell dysfunction could be related to impaired insulin secretion due 
to many reasons, including insufficient β-cell mass, impaired regenerative capability and/or functional defects 
of the β cells, as well as structural/functional defects in surrounding tissues, such as the vascular and exocrine 
compartments.
Tcf7l2 knockout mice or Tcf7l2/Tcf7 double knockout mice have shown defects in gut development, but no 
abnormalities have been reported in pancreas development38, 39. The zebrafish tcf7l2 null mutant shows clear mor-
phological defects at 4 weeks post-fertilization and is not viable after 6 wpf19. The phenotype comprises a loss of 
proliferation at the base of the intestinal folds of the middle and distal parts of the intestine. In our study, we have 
detected decreased proliferation as well as increased cell death in the pancreatic region of zebrafish tcf7l2 mutants, 
suggesting that both impaired tissue growth and reduced cell survival may underlie the observed pancreatic 
phenotypes. On the other way, the chronic elevation of blood glucose, that we have observed in the tcf7l2 mutant, 
could have negative long-term effects on β-cell proliferation in the zebrafish as it does for mice40.
We have evaluated the regenerative capabilities of β cells in tcf7l2 mutants, after tissue-specific induced dam-
age. The zebrafish is a key genetic model system for vertebrate regeneration research; in this study we have taken 
advantage of available transgenic lines expressing nitroreductase (NTR) in β cells. NTR converts the pro-drug 
metronidazole to a toxin, resulting in β-specific cell death23, 41. With this ablation strategy, we could observe an 
impairment of β-cell regeneration in tcf7l2 mutants. The limited regeneration of β cells found in heterozygous fish 
can be controlled by both systemic and local factors42; in other words, it can be a pancreatic-specific feature or a 
more general condition due to multi-tissue defects. The caudal fin is a suitable model for studying the molecular 
mechanisms regulating regeneration due to its accessibility and its relatively simple structure. In this study, we 
have examined caudal fin regeneration after amputation and confirmed that tcf7l2 mutants are generally affected 
in their growth and regeneration capacities. Therefore, the tcf7l2 mutant presented here appears as a valid tool to 
study diabetes and its regenerative complications.
We have also assessed if defects in the vascular compartment could be present in tcf7l2 mutants, thus possibly 
contributing to the diabetic phenotype. Islets are indeed strongly vascularized, as their ability to sense blood glu-
cose and release insulin depends on close contact with blood vessels; the failure of an adaptive response between 
blood vessels and β cells in the islet contributes to diseases such as T2D. Indeed, vascular pericytes are supporting 
cells of the islet vasculature that serve to regulate capillary blood flow and permeability, influencing changes in 
β-cell mass43. Interestingly, β cells secrete both pro- and anti-angiogenic factors that have been implicated in 
hyperglycaemia-induced maculopathy in adults44. In particular, angiogenic factors, including vascular endothe-
lial growth factor (VEGF) are secreted from β cells, maintaining a dense and fenestrated capillary network; also, 
VEGF receptors are differentially expressed in islets versus acinar endothelium31.
We have observed vascular defects in tcf7l2 mutant larvae with transgenic backgrounds fli1:eGFP/ins:dsRED, 
when analysed at 16 dpf (homozygous tcf7l2exI/exI) and in adults (heterozygous tcf7l2exI/+). Confocal microscopy of 
transgenic ins:dsRED/tcf7l2exI/exI mutants at 16 dpf shows a reduction in the number of β cells, and the analysis of 
transgenic fli1:eGFP/ins:dsRED/tcf7l2 mutants indicates morphological abnormalities, with a statistically relevant 
reduction in the number and diameter of pancreatic islet capillaries.
If this effect of tcf7l2 on blood vessels is indirectly exerted from adjacent tissues, or directly due to tcf7l2 
expression in vascular cells could not be fully clarified, due to vascular expression levels of tcf7l2 undetecta-
ble by whole-mount in situ hybridization. However, based on our PCR amplification of tcf7l2 transcripts 
in endothelial-enriched samples, a direct role of tcf7l2 on the vascular compartment cannot be excluded. 
Interestingly, according to the Unigene database, human TCF7L2 ESTs are also consistently detected in blood 
vessels. Moreover, our evidence of reduced insulin transgene expression, following vascular-specific perturbation, 
fully supports the hypothesis that mutations in Tcf7l2 might affect β-cell function through the mediation of the 
vascular compartment.
We have also considered the exocrine tissue in our evaluation of the tcf7l2 phenotype. The analysis of adult 
tcf7l2exI/+ heterozygous individuals with transgenic backgrounds Tg(ptf1a:DsRed) or Tg(ela3l:E2Crimson) 
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revealed a loss of acinar organization of the exocrine cells in the mutants. This could represent a consequence of 
the close anatomical, metabolic and functional links between the exocrine and endocrine pancreas, so that any 
disease affecting one of these parts will inevitably affect the other29, 45.
In conclusion, additional mechanistic studies are needed to fully evaluate different Tcf7l2 models (zebrafish, 
rodents) and compare them with human patients in terms of compensation in the Lef/Tcf transcription factor 
family, genetic background and efficiency of gene ablation or inhibition. We should also consider the possibility 
that disease alleles may promote an imbalance of alternative splice forms of TCF7L2, thereby resulting in protein 
isoforms with opposing physiological effects36.
It is important to consider that TCF7L2 is expressed in a broad spatial domain pattern, including tissues with 
important roles in glucose metabolism such as gut, brain, liver, skeletal muscle, fat, and bones46. This raises the 
possibility that, in vivo, TCF7L2 may not directly regulate glucose metabolism primarily through actions in β 
cells, but rather in tissues outside the endocrine islet, such as liver11, vasculature or exocrine pancreas.
As summarized in Table 1, we observed: (a) impaired glucose homeostasis in β cells deficient for tcf7l2; (b) an 
altered morphology of pancreas and pancreatic vessels; (c) defects in the regeneration of fins and β cells.
Prior studies provided evidence that pancreatic growth and differentiation are regulated by Wnt signalling47–53. 
However, these works did not present a mechanism for the Tcf7l2-mediated action. Our results collectively sug-
gest that Tcf7l2 is required in late steps of pancreas development, leading to a pleiotropic model that links Tcf7l2 
and T2D pathogenesis, with independent pancreatic (our study) and hepatic (other studies) contributions to the 
pathogenesis.
This zebrafish model of TCF7L2-linked dysfunction lends itself well to high throughput approaches, such as 
small molecule screens that can potentially be coupled with transgenic tools, including reporters of gene function, 
or β-cell ablation and regeneration. Such approaches open the chance for zebrafish to become an essential drug 
discovery and screening tool for the future of diabetes research.
Material and Methods
Zebrafish husbandry and transgenic lines. Animals were staged and fed as described by Kimmel et al.54. 
All animal experiments were performed in accordance with the European and Italian Legislations and with the 
specific permission for animal experimentation of the Local Ethics Committee. The project was examined and 
approved by the Ethics Committee of the University of Padua with protocol number 18746.
Tcf7l2 mutant carriers were identified as described in Muncan et al.19. For functional in vivo studies we 
used the following fish lines, that where crossed with the tcf4hu892 or tcf4exI/exI mutant19: Tg(fli1a:EGFP)y128, 
Tg(kdrl:mcherry)is555, Tg(ins:EGFP)56, Tg(7xTCF-Xla.Siam:GFP)ia426, Tg(ptf1a:EGFP)jh1, Tg(ptf1a:DsRed)ia6, 
Tg(gcga:GFP)ia125 Tg(ela3l:caspase;ela3l:E2Crimson) (line abbreviated to Tg(ela3l:E2Crimson))57, 
Tg(−1.2ins:DsRed)56 referred to as Tg(ins:DsRed), and Tg(ins:NTR-mCherry)ml10 (Dirk Meyer’s Lab) expressing 
a nitroreductase (NTR)-mCherry fusion protein in β cells. For β-cell ablation, the Tg(ins:NTR-mCherry)ml10 line 
has been managed as described in Curado et al.58.
Blood glucose measurement. Before postprandial analysis of glucose levels, each animal was fed with 
25 mg of dry food (Tetramin Bioactive flakes, Tetra GmbH). Two different protocols for blood collection from 
zebrafish were used for the analysis of blood glucose.
In the first method, to obtain whole blood, fish were anesthetized with tricaine and ice-cold water and then 
cut cleanly through the pectoral girdle with scissors. The cut was immediately anterior to the articulation of the 
pectoral fin with the girdle, and severed the heart. Whole blood was analyzed immediately by applying a test strip 
directly to the cardiac blood. With this method, the quantity of blood collected depends on the size of the fish. We 
found that approximately 5 μl was typical, but as much as 10 μl was not uncommon as described in Eames et al.20.
The second method used is based on a non-lethal protocol for blood collection from zebrafish, as illustrated 
in Zang et al.22. Briefly, animals were tricaine-anesthetised, placed on a paper towel and gently dried. The needles 
were made from 1.0 mm-outer-diameter glass capillaries, pre-rinsed with 5 mg/ml heparin, and inserted in the 
tail region of the fish. The collected blood (0.5–1 ul) was placed on a piece of parafilm for measurement. After 
delicate pressure on the perforated skin area, the fish were transferred to a clean water tank and gently swirled 
for recovery.
The following glucose meters and test strips were used: Accu-Chek Aviva, for 0.6 μL samples (Roche 
Diagnostics), and GlucoMen LX sensor (Menarini Diagnostics), the latter suitable for blood volumes less than 
0.5 μL.
tcf7l2exI/+ tcf7l2exI/exl
Hyperglycaemia ✓7 mpf
Defects in beta cells ✓9 mpf ✓16 dpf
Defects in exocrine pancreas ✓9 mpf ✓14 dpf
Defects in blood vessels ✓18 dpf
Altered regeneration of the fin ✓7 mpf
Altered regeneration of beta cells ✓7 mpf ✓7 dpf
Table 1. Summary of detected phenotypes in heterozygous (tcf7l2exI/+) and homozygous (tcf7l2exI/exI) mutants. 
Tcf7l2 mutant phenotypes were detected at the indicated stages.
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Expression levels of Tcf/Lef genes. Expression levels of tcf7l2, tcf7l1a, tcf7l1b, tcf7 and lef1 were obtained 
from RNAseq datasets prepared from purified mature pancreatic cells from adult zebrafish; these transcriptomic 
analyses will be presented in detail elsewhere (Tarifeño-Saldivia et al., manuscript in preparation). Briefly, the 
distinct endocrine cell types were prepared using the transgenic lines Tg(insulin:GFP) (created by Marianne 
Voz, unpublished line), Tg(gcga:GFP/ins:mCherry)ia125, and Tg(sst2:GFP)59 to isolate β, α and δ cells respec-
tively. Acinar cells were isolated by using Tg(ptf1a:GFP)60. RNAs were purified from sorted cells and analysed by 
RNAseq. Sequenced samples were mapped to the zebrafish genome (Zv9, Ensembl genome version 75, http://
www.ensembl.org) using the TopHat software61. ‘Per gene’ expression level was estimated using HTSeq-count62 
and posterior normalization (library size) was performed using DESeq software63, 64.
RNA extraction, reverse transcription and quantitative polymerase chain reaction (qPCR). 
Total mRNA was isolated from different tissues of adult zebrafish using Trizol (Invitrogen, Carlsbad, CA), and 
1 μg of total RNA reverse-transcribed using M-MLV Reverse Transcriptase RNase H- (Solis BioDyne).
qPCRs were performed in triplicate with EvaGreen method using a Rotor-gene Q (Qiagen) and the 5x HOT 
FIREPol ® EvaGreen® qPCR Mix Plus (Solis BioDyne) following the manufacturer’s protocol. The cycling param-
eters were: 95 °C for 14 min, followed by 45 cycles at 95 °C for 15 s, 59 °C for 35 s, and 72 °C for 25 s. Threshold 
cycles (Ct) and dissociation curves were generated automatically by Rotor-Gene Q series software. Sequences of 
specific primers used in this work are listed in supplementary material Table S1. Primers were designed using 
the software Primer 3 (http://bioinfo.ut.ee/primer3–0.4.0/input.htm). Sample Ct values were normalized with Ct 
values from zebrafish elongation factor-1a (ef1a) and arp.
Whole-mount in situ hybridization. Embryos were staged according to Kimmel et al.54. Whole-mount in 
situ hybridizations on tcf7l2 embryos and wt siblings were performed according to Thisse et al.65. The following 
digoxygenin- or fluorescein-labelled (Roche) antisense riboprobes were used: insulin66 and tcf7l2 R9 (kindly pro-
vided by H. Clevers). Control and mutant embryos have been hybridized in the same tube; control embryos had 
the tip of the tail cut. Following in situ hybridization, embryos were post-fixed in 4% buffered p-formaldehyde 
and mounted in 85% glycerol/phosphate-buffered saline (PBS) for microscope observation. Observations were 
made with a Leica DMR compound/Nomarski microscope and images were acquired with a Leica DC500 digital 
camera.
Confocal analysis and vessel diameter measurements. Fluorescence was visualized under a Leica 
M165FC dissecting microscope and then with a Nikon C2 H600L confocal microscope. For in vivo analyses, 
embryos and larvae were anesthetised with tricaine and mounted in 1% low melting agarose gel. EGFP and 
mCherry fluorescence was visualized by using 488 and 561 nm lasers, respectively, through 20x and 40x immer-
sion objectives (Nikon). All images were analyzed with Fiji software67.
Vessels were automatically segmented on the EGFP fluorescence image stack, by using a level set method 
(adapted from ref. 68) which takes into account the variability in the appearance of the vessel-related fluores-
cence. As long as the image intensity of the areas belonging to a vessel remains significantly higher than the back-
ground signal, it is considered as being part of a vessel. The methods incorporate three regularization parameters 
to make the estimation of abnormally large or irregular vessels unlikely.
The diameter at each point along a vessel centreline was estimated using a multi-stencil fast marching method 
(refs 69 and 70), which reliably computes the distance of a point from the object boundary.
With the same level set method68 used for segmenting the vessels, the β-cells boundaries were segmented on 
the mCherry fluorescence image stack.
A spherical region of interest was then drawn centred on the detected β-cell centroid and with a fixed radius 
of 0.1 mm.
All voxels belonging to a vessel centreline within this region have been considered, and their statistics meas-
ured: vessel density, mean diameter, and diameter standard deviation.
EdU staining. To label proliferating cells in zebrafish, larvae were treated with EdU using the Click-iT 
Imaging Kit (Invitrogen C10085) adapted by S. Eckerle and J. Holzschuh71. At 6 dpf, larvae were incubated in EdU 
solution (10 mM EdU and 5% DMSO in fish water) for 25 minutes at RT to allow uptake of EdU into the embryos. 
The treated larvae were successively incubated at 28.5 °C for 3 days to allow the incorporation of EdU into the 
DNA of proliferating cells (S Phase). Samples were fixed in 4% PFA/1% DMSO for 2 h at room temperature (RT), 
washed in 1x PBST and de-yolked. EdU staining was performed as previously described72.
AO staining. Cell death in whole zebrafish larvae was measured with vital dye acridine orange staining. Live 
embryos were immersed in 5 μg/ml acridine orange (Sigma), dissolved in PBS, in the dark for 30 min. Fluorescent 
signals were visualized with a Leica M165FC dissecting microscope, and images were acquired with a Leica 
DC7000 digital camera.
Fin Regeneration. Fin regeneration studies were performed as previously described73. Zebrafish were anes-
thetized with tricaine and tail fins were cut with a scalpel immediately close to the proximal branch point of the 
dermal rays within the fin. Following amputation, fish were incubated at 28 °C for the indicated periods of time. 
The fish were again anesthetized, the regenerating fins were observed at 72 hours with a Leica M165FC dissecting 
microscope, and images were acquired with a Leica DC500 digital camera. The area of regeneration was divided 
by the dorso-ventral length of the fin to normalize the amount of regeneration for fish of different sizes.
Larvae dissociation and fluorescence activated cell sorting (FACS). Wild type Tg(fli1a:EGFP)y1 
larvae at 6 dpf were dissociated as previously described (Zancan et al.)74 using 1x PBS, 0.25% trypsin phenol red 
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free, 1 mM EDTA pH 8.0, 2.2 mg/ml Collagenase P (Sigma). Digestion was stopped by adding CaCl2 to a final 
concentration of 1 mM and fetal calf serum to 10%. Dissociated cells were rinsed once in PBS and resuspended 
in Opti-MEM (Gibco), 1% fetal calf serum and 1X Penicillin-Streptomycin solution (Sigma). Cells were filtered 
through a 40 μm nylon membrane and subjected to FACS (S3 Cell Sorter, Bio-Rad) with laser set at 488 nm and a 
586/25 nm filter. GFP+ and GFP− cells were separately collected in resuspension medium, and RNA was extracted 
using the RNA isolation kit Nucleospin® RNA XS (Macherey-Nagel).
Statistical analysis. Statistical analysis was performed using Graph Pad Prism V6.0. Data are presented 
as the means ± SEM. The differences between the means were tested for significance using the non-parametric 
t-Student Test. A difference between two means was considered to be significant when p < 0.05 (*p < 0.05). 
Correction for multiple comparison (either using the over-stringent Bonferroni correction75, 76, or False Discovery 
Rate77 has not been performed. Given the sample size and exploratory nature of the study, we prefer to report 
possible false positive effects (Type II error, minimized through multiple comparison correction) than to exclude 
possibly relevant effects (Type I error, usually enhanced when applying multiple comparison correction).
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